Energy Before Amyloid: Why Mitochondrial Dysfunction May Drive Neurodegeneration
What If Alzheimer’s Is an Energy Problem?
We have spent decades framing Alzheimer’s disease as a story about proteins. Amyloid plaques build up, neurons die, and memory unravels. But what if the protein buildup is a consequence, not a cause? What if the real story begins far upstream, inside the mitochondria, where the brain’s energy is made?
That is the framework Dr. Robert Lustig presented at the BlueOakNx first annual symposium on mitochondrial health, health span, and aging. Each step in the model is grounded in published research, though the full causal chain connecting these steps into a unified theory of neurodegeneration is still being assembled by the field.
Watch the entire talk here:
The Setup: A Cell Running Low
Mitochondria convert glucose into ATP, the molecule that powers virtually every biological process. In doing so, they generate byproducts called reactive oxygen species, or ROS. At normal levels, ROS serve as internal signals. When they accumulate, they signal the cell to divert energy away from burning energy toward storage of energy. In the brain, that means less ATP. The first signs are subtle: brain fog, difficulty concentrating, dips in cognition.
The Pressure Builds: Stress Enters the Picture
Now layer in chronic stress. Cortisol does not simply affect mood. At the cellular level, it increases the metabolic demands placed on neurons, a phenomenon Dr. Martin Picard at Columbia University has documented as neuronal hypermetabolism. The cell is now caught in a squeeze: elevated ROS have reduced ATP production while stress has simultaneously increased ATP consumption. The neuron is running a deficit.
When the Energy Runs Out
This is where amyloid precursor protein becomes relevant. It is present in neurons throughout the brain, and how it gets cleaved depends in part on ATP availability. When ATP falls, the cleavage shifts in a direction that produces amyloid fragments. These fragments accumulate into the plaques that are the hallmark of Alzheimer’s pathology.
At the same time, ROS stimulates inflammatory signaling pathways, including NF-kB and the inflammasome. Inflammation compounds the damage. The result is plaque formation, circuit failure, and eventually neuronal death.
Why This Framing Matters
If Alzheimer’s is fundamentally an energy crisis at the cellular level, then the upstream question becomes: what is generating excess ROS in the first place? The answer implicates a wide range of factors, including dietary fructose, environmental chemicals, air pollution, sleep deprivation, and chronic psychological stress. These are not random influences. They are modifiable.
Notably, the same ATP deficit that this model links to neurodegeneration also maps onto the cellular conditions associated with depression and cognitive impairment. When neurons cannot meet their energy demands, the consequences are not limited to plaque formation. They show up earlier, and in ways clinicians recognize daily: mood dysregulation, attentional difficulty, and mental fatigue. The mitochondrial framework does not draw a hard line between neurological and psychiatric disease. That continuity is worth sitting with.
Understanding neurodegeneration and mental health through the lens of mitochondrial function does not simplify the science. But it may offer a more tractable path for understanding why these conditions develop, why they so often co-occur, and how their progression might one day be interrupted at a common root.
